Contact Us
4701 Sangamore Road, #100N
Bethesda, MD 20816
301-818-9810
[email protected]
We have patented a novel naloxone dosage form.

Pocket Naloxone Corp.

Developing a cost effective, simple, ready-to-use Naloxone product.

70,000 +

Opioid Overdose Deaths

Every 6-7 minutes, someone in America dies from an opioid overdose. There were over 70,000 opioid overdose deaths in 2020

35,000,000 +

At Risk of An Overdose

This population comprises about 19M high-impact chronic pain patients taking higher doses of opioids, about 11M misusing heroin or fentanyl primarily to alleviate pain, and others on opioid use disorder treatments

140,000,000 +

Opioid Prescriptions Written

142,816,781 opioid prescriptions were written in 2020. This corresponds to a dispensing rate of 43.3 prescriptions per 100 persons

PRESS RELEASE

NaxSwab™ OTC novel naloxone nasal swab successfully administered by children and adults to potentially rescue someone from an opioid overdose in study.

"Human Factors Validation Study demonstrated that adolescents and adults could follow the instructions to correctly administer NaxSwab™ OTC in a simulated emergency environment"
PRESS RELEASE

Naloxone Startup Pursues FDA Approval for Over-the-Counter Swab.

"The FDA has encouraged pharmaceutical companies to apply for approval for over-the-counter versions of naloxone to combat the overdose crisis from bootleg fentanyl."
PRESS RELEASE

NaxSwab™ OTC novel naloxone nasal swab demonstrates faster absorption and higher early exposures against other naloxone products in clinical study.

"Pharmacokinetic study data in healthy volunteers shows NaxSwab™ OTC has 74% and 1096% higher exposures at 2.5 minutes compared to naloxone HCI 4mg nasal spray and 0.4mg IM naloxone injection"